Send to

Choose Destination
Turk J Urol. 2017 Dec;43(4):401-409. doi: 10.5152/tud.2017.06978. Epub 2017 Dec 1.

Biparametric MRI of the prostate.

Author information

Department of Surgical and Biomedical Sciences, Division of Radiology 2, Santa Maria della Misericordia Hospital, Perugia University, Sant' Andrea delle Fratte, Perugia, Italy.
Department of Experimental Medicine, Magrassi Lanzara, Luigi Vanvitelli, Second University of Naples, Naples, Italy.
Department of Urology, Clinica Castelli, Bergamo, Italy.
Department of Surgical and Biomedical Sciences, Division of Gynaecology, Santa Maria della Misericordia Hospital, Perugia University, Sant' Andrea delle Fratte, Perugia, Italy.
Division of Urology, Portogruaro Hospital, Venice, Italy.
Health Management, S. Maria della Misericordia Hospital, Sant' Andrea delle Fratte, Perugia, Italy.
Department of Radiology, Casa Sollievo della Sofferenza Hospital, Foggia, Italy.
3DIFIC, Medical Area, University of Perugia, Perugia, Italy.
Division of Urology, University of Modena, Modena, Italy.
Department of Radiology, Campobasso University, C.da Tappino, Campobasso, Italy.

Erratum in


Biparametric Magnetic Resonance Imaging (bpMRI) of the prostate combining both morphologic T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) is emerging as an alternative to multiparametric MRI (mpMRI) to detect, to localize and to guide prostatic targeted biopsy in patients with suspicious prostate cancer (PCa). BpMRI overcomes some limitations of mpMRI such as the costs, the time required to perform the study, the use of gadolinium-based contrast agents and the lack of a guidance for management of score 3 lesions equivocal for significant PCa. In our experience the optimal and similar clinical results of the bpMRI in comparison to mpMRI are essentially related to the DWI that we consider the dominant sequence for detection suspicious PCa both in transition and in peripheral zone. In clinical practice, the adoption of bpMRI standardized scoring system, indicating the likelihood to diagnose a clinically significant PCa and establishing the management of each suspicious category (from 1 to 4), could represent the rationale to simplify and to improve the current interpretation of mpMRI based on Prostate Imaging and Reporting Archiving Data System version 2 (PI-RADS v2). In this review article we report and describe the current knowledge about bpMRI in the detection of suspicious PCa and a simplified PI-RADS based on bpMRI for management of each suspicious PCa categories to facilitate the communication between radiologists and urologists.


Biparametric magnetic resonance imaging; prostate cancer; prostate imaging reporting and data system

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center